- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Trodelvy granted accelerated approval by USFDA for metastatic urothelial cancer | ||
| Mi | Dr. Reddy's secures EUA for Sputnik V in India | ||
| Di | Airway Therapeutics' IND application for AT-100 gets FDA acceptance to treat Covid-19 | ||
| Mo | Sanofi acquires Tidal Therapeutics | ||
| Fr | Biogen and Bio-Thera Solutions announce commercialisation and license agreement for BAT1806 | ||
| 08.04. | AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis | ||
| 07.04. | USFDA extends review period for Eli Lilly and Incyte's sNDA for baricitinib | ||
| 07.04. | AB Science and University of Chicago to conduct Covid-19 treatment research | ||
| 06.04. | Antengene announces China's NMPA approval for IND application for ATG-019 clinical trial | ||
| 06.04. | Anixa and OntoChem enter next stage of Covid-19 anti-viral therapy development | ||
| 05.04. | AbbVie announces extension of USFDA review period for Rinvoq sNDA | ||
| 01.04. | Piramal to acquire APIs manufacturer Hemmo Pharmaceuticals | ||
| 01.04. | Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m | ||
| 31.03. | Amgen agrees to acquire biopharmaceutical company Rodeo Therapeutics | ||
| 30.03. | USFDA sends CRL to Merck's sBLA regarding KEYTRUDA | ||
| 29.03. | USFDA approves Abecma to treat relapsed or refractory multiple myeloma | ||
| 26.03. | Japan approves Bristol Myers Squibb's B-cell lymphoma therapy | ||
| 26.03. | EMA validates Gilead Sciences' application for breast cancer therapy | ||
| 26.03. | US NIH-led study identifies SARS-CoV-2 virus infects cells in mouth | ||
| 25.03. | UCLA-led lab study identifies potential drug to treat SARS-CoV-2 virus | ||
| 24.03. | Fidia Farmaceutici acquires Sanofi's anti-inflammatory drugs portfolio | ||
| 23.03. | FDA approves Zealand Pharma's Zegalogue for hypoglycemia treatment | ||
| 23.03. | Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines | ||
| 22.03. | USFDA approves Janssen's PONVORY for treatment of multiple sclerosis | ||
| 19.03. | Anima signs new strategic collaboration deal with Takeda |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
